April 28, 2026 FDA Clears Breztri for Asthma Use Single-inhaler triple therapy improved lung function vs dual therapy in phase 3 trials and showed rapid onset without new safety signals. Conexiant
April 28, 2026 This Week’s Biopharma News: Wave of Antibody Approvals FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars The Medicine Maker
April 17, 2026 AI Scribes Lag Clinicians on Note Quality A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness Conexiant
April 16, 2026 GLP-1 Drugs Linked to GI Effects, Uncertain Signals Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects. Conexiant
April 16, 2026 Viral, Fungal Infections May Contribute to Nonresolving ARDS Review links viral and fungal infections to persistent lung injury in nonresolving ARDS Conexiant
April 16, 2026 Mandatory Training Modules Deserve a Harder Look A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment. Conexiant
April 13, 2026 Temple Lung Center: Advances in Lung Care and Research in 2025 Pulmonary care is evolving rapidly, from earlier detection strategies to new minimally invasive therapies and expanding access to clinical trials. Temple Health
April 13, 2026 AI Falls Short on Differential Dx New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models Conexiant
April 07, 2026 Brief Prehabilitation Reduced Complications Prior to Gastrectomy Researchers evaluate a supervised, home-based program combining exercise, nutrition, and psychological support before surgery Conexiant
April 06, 2026 The Loan Cap That Could Shrink the Doctor Pipeline New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice. Conexiant